Smoking Cessation’s Quiet Design Failure
The gap between how nicotine use has evolved and how cessation treatment has evolved is a meaningful part of why quit rates have plateaued.
Mario Danek
Mario Danek is the founder and CEO of Qnovia, Inc., a pharmaceutical and medtech company he launched in 2018 to develop a next-generation inhaled drug delivery platform that improves patient outcomes. A lifelong entrepreneur and inventor, Danek leads Qnovia’s mission to transform smoking cessation and respiratory care through breakthrough aerosol devices and formulations. Danek currently oversees the launch of Qnovia’s RespiRx platform, which combines an FDA clinical-stage smoking cessation therapy with an AI-enabled behavioral health coach to help the world’s one billion smokers quit for good.